• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物群与免疫系统——胃癌故事中的角色

Microbiota and the Immune System-Actors in the Gastric Cancer Story.

作者信息

Majewski Marek, Mertowska Paulina, Mertowski Sebastian, Smolak Konrad, Grywalska Ewelina, Torres Kamil

机构信息

2nd Department of General, Gastrointestinal Surgery and Surgical Oncology of the Alimentary Tract, Medical University of Lublin, 20-081 Lublin, Poland.

Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.

出版信息

Cancers (Basel). 2022 Aug 8;14(15):3832. doi: 10.3390/cancers14153832.

DOI:10.3390/cancers14153832
PMID:35954495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9367521/
Abstract

Gastric cancer remains one of the most commonly diagnosed cancers in the world, with a relatively high mortality rate. Due to the heterogeneous course of the disease, its diagnosis and treatment are limited and difficult, and it is associated with a reduced prognosis for patients. That is why it is so important to understand the mechanisms underlying the development and progression of this cancer, with particular emphasis on the role of risk factors. According to the literature data, risk factors include: changes in the composition of the stomach and intestinal microbiota (microbiological dysbiosis and the participation of ), improper diet, environmental and genetic factors, and disorders of the body's immune homeostasis. Therefore, the aim of this review is to systematize the knowledge on the influence of human microbiota dysbiosis on the development and progression of gastric cancer, with particular emphasis on the role of the immune system in this process.

摘要

胃癌仍然是世界上最常被诊断出的癌症之一,死亡率相对较高。由于该疾病病程的异质性,其诊断和治疗受到限制且困难,并且与患者预后不良相关。这就是为什么了解这种癌症发生和发展的潜在机制如此重要,尤其要强调风险因素的作用。根据文献数据,风险因素包括:胃和肠道微生物群组成的变化(微生物失调及相关参与情况)、不当饮食、环境和遗传因素以及机体免疫稳态紊乱。因此,本综述的目的是系统整理关于人类微生物群失调对胃癌发生和发展影响的知识,尤其强调免疫系统在此过程中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/1c775aea627e/cancers-14-03832-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/4884e50b1be4/cancers-14-03832-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/6c9d26a604d7/cancers-14-03832-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/ed2f8b1f2311/cancers-14-03832-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/995c480798a0/cancers-14-03832-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/598ca276ef3a/cancers-14-03832-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/0640674938c2/cancers-14-03832-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/c54332c272cb/cancers-14-03832-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/1c775aea627e/cancers-14-03832-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/4884e50b1be4/cancers-14-03832-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/6c9d26a604d7/cancers-14-03832-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/ed2f8b1f2311/cancers-14-03832-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/995c480798a0/cancers-14-03832-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/598ca276ef3a/cancers-14-03832-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/0640674938c2/cancers-14-03832-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/c54332c272cb/cancers-14-03832-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a7/9367521/1c775aea627e/cancers-14-03832-g008.jpg

相似文献

1
Microbiota and the Immune System-Actors in the Gastric Cancer Story.微生物群与免疫系统——胃癌故事中的角色
Cancers (Basel). 2022 Aug 8;14(15):3832. doi: 10.3390/cancers14153832.
2
Gastrointestinal microbiome and : Eradicate, leave it as it is, or take a personalized benefit-risk approach?胃肠道微生物组与:根除、保留原状,还是采取个体化的获益-风险方法?
World J Gastroenterol. 2022 Feb 21;28(7):766-774. doi: 10.3748/wjg.v28.i7.766.
3
Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies.胃微生物群:在幽门螺杆菌引起的胃部恶性肿瘤中崭露头角的新角色。
Cancer Lett. 2018 Feb 1;414:147-152. doi: 10.1016/j.canlet.2017.11.009. Epub 2017 Nov 11.
4
The Effects of Infection on Microbiota Associated With Gastric Mucosa and Immune Factors in Children.感染对儿童胃黏膜相关菌群及免疫因子的影响。
Front Immunol. 2021 Mar 24;12:625586. doi: 10.3389/fimmu.2021.625586. eCollection 2021.
5
Effect of Eradication on Human Gastric Microbiota: A Systematic Review and Meta-Analysis.根除对人类胃微生物群的影响:系统评价和荟萃分析。
Front Cell Infect Microbiol. 2022 May 4;12:899248. doi: 10.3389/fcimb.2022.899248. eCollection 2022.
6
Modification of the Gastric Mucosal Microbiota by a Strain-Specific Helicobacter pylori Oncoprotein and Carcinogenic Histologic Phenotype.一种特定菌株的幽门螺杆菌致癌蛋白和致癌组织学表型对胃黏膜微生物群的修饰。
mBio. 2019 May 28;10(3):e00955-19. doi: 10.1128/mBio.00955-19.
7
Influence of Factors Altering Gastric Microbiota on Bariatric Surgery Metabolic Outcomes.改变胃微生物群的因素对减重手术代谢结果的影响。
Microbiol Spectr. 2021 Dec 22;9(3):e0053521. doi: 10.1128/Spectrum.00535-21. Epub 2021 Nov 17.
8
Microbial community reshaped in gastric cancer.胃癌中微生物群落的重塑。
Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7257-7264. doi: 10.26355/eurrev_201811_16260.
9
Imbalance of Gastrointestinal Microbiota in the Pathogenesis of Helicobacter pylori-Associated Diseases.幽门螺杆菌相关疾病发病机制中胃肠道微生物群的失衡
Helicobacter. 2016 Oct;21(5):337-48. doi: 10.1111/hel.12297. Epub 2016 Feb 15.
10
Effect of on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer.在胃癌高发区临朐基于人群的研究:对胃肠道微生物群的影响。
Gut. 2020 Sep;69(9):1598-1607. doi: 10.1136/gutjnl-2019-319696. Epub 2019 Dec 19.

引用本文的文献

1
Comparison of gastric microbiota in patients with different gastric lesions in high and low risk areas of gastric cancer.胃癌高低发区不同胃部病变患者的胃微生物群比较
BMC Microbiol. 2025 Apr 9;25(1):202. doi: 10.1186/s12866-025-03926-4.
2
Gut Microbiota-Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer.肠道微生物群与肿瘤微环境的相互作用:对癌症免疫检查点抑制剂疗效的机制及临床意义
Cancer Manag Res. 2025 Jan 25;17:171-192. doi: 10.2147/CMAR.S405590. eCollection 2025.
3
Complex immune network and regional consistency in the human gastric mucosa revealed by high-resolution spectral cytometry.

本文引用的文献

1
The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer.人类肠道微生物群在胃肠道癌症中的新兴作用。
Front Immunol. 2022 Jun 15;13:915047. doi: 10.3389/fimmu.2022.915047. eCollection 2022.
2
Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer.肠道微生物群对胃肠道癌症的免疫调节作用:聚焦于结直肠癌
Cancers (Basel). 2022 Apr 25;14(9):2140. doi: 10.3390/cancers14092140.
3
The Implication of Gastric Microbiome in the Treatment of Gastric Cancer.胃微生物群在胃癌治疗中的意义
高分辨率光谱流式细胞术揭示人类胃黏膜中的复杂免疫网络和区域一致性
Sci Rep. 2024 Nov 19;14(1):28685. doi: 10.1038/s41598-024-78908-z.
4
Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer.肠道微生物组衍生的丁酸盐可抑制胃癌中肿瘤相关巨噬细胞中的免疫抑制因子 PD-L1 和 IL-10。
Gut Microbes. 2024 Jan-Dec;16(1):2300846. doi: 10.1080/19490976.2023.2300846. Epub 2024 Jan 10.
5
Intratumor microbiome: selective colonization in the tumor microenvironment and a vital regulator of tumor biology.肿瘤内微生物群:在肿瘤微环境中的选择性定殖及肿瘤生物学的重要调节因子
MedComm (2020). 2023 Sep 26;4(5):e376. doi: 10.1002/mco2.376. eCollection 2023 Oct.
6
Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?Toll 样受体 2 能否作为检测晚期胃癌的生物标志物?
Int J Mol Sci. 2023 Mar 18;24(6):5824. doi: 10.3390/ijms24065824.
Cancers (Basel). 2022 Apr 18;14(8):2039. doi: 10.3390/cancers14082039.
4
The role of key gut microbial metabolites in the development and treatment of cancer.关键肠道微生物代谢物在癌症发展和治疗中的作用。
Gut Microbes. 2022 Jan-Dec;14(1):2038865. doi: 10.1080/19490976.2022.2038865.
5
Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?肠道微生物组失调、脂代谢与肿瘤发生的相互作用:肠道微生物组失调能否成为癌症的预后标志物?
Dis Markers. 2022 Feb 8;2022:2941248. doi: 10.1155/2022/2941248. eCollection 2022.
6
Oral Species and Their Connection to Events of Clinical Relevance in Gastrointestinal and Respiratory Tracts.口腔物种及其与胃肠道和呼吸道临床相关事件的联系。
Front Microbiol. 2022 Jan 6;12:798763. doi: 10.3389/fmicb.2021.798763. eCollection 2021.
7
colonization is associated with decreased survival of -positive gastric cancer patients.定植与阳性胃癌患者的生存降低有关。
World J Gastroenterol. 2021 Nov 14;27(42):7311-7323. doi: 10.3748/wjg.v27.i42.7311.
8
Comparison of East-Asia and West-Europe cohorts explains disparities in survival outcomes and highlights predictive biomarkers of early gastric cancer aggressiveness.东亚和西欧队列的比较解释了生存结果的差异,并强调了早期胃癌侵袭性的预测生物标志物。
Int J Cancer. 2022 Mar 1;150(5):868-880. doi: 10.1002/ijc.33872. Epub 2021 Dec 9.
9
A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects.慢性肾脏病与肠道微生物群在免疫和营养方面的关联。
Nutrients. 2021 Oct 17;13(10):3637. doi: 10.3390/nu13103637.
10
Overgrowth of in gastric cancer.胃癌中……的过度生长。 你提供的原文“Overgrowth of in gastric cancer.”似乎不完整,有缺失部分。
World J Gastrointest Oncol. 2021 Sep 15;13(9):1099-1108. doi: 10.4251/wjgo.v13.i9.1099.